Clinical Trial Update: Metabolic Support With Perhexiline to Protect Myocardium Undergoing Coronary Artery Surgery [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating metabolic support with perhexiline to protect the myocardium during coronary artery surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Cardiac Output Syndrome
• Myocardial Reperfusion Injury

Drugs mentioned

• Perhexiline (perhexiline)

Snippet

Sponsor: University Hospital Birmingham | Conditions: Myocardial Reperfusion Injury, Cardiac Output, Low | Phase 2, Phase 3 | Status: COMPLETED